Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2009-02-28
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators want to do a randomized trial. One group will be treated as they have been treated at Ullevål University Hospital (UUS) in recent years, and the other group will be returned to their refering hospital the same day. The objective of this study will be to provide increased knowledge about whether the rapid discharge from the intervention center is associated with differences in costs or security.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is to see if one can reduce the hospital stay and costs for the intervention center, and the total hospitalization time.
and this rapid transport not give more medical complications
Our 1 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day, will reduce the length of stay in intervention center without an increase for the stay at the refering hospital.
Our 2 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day as the treatment is performed, have no more complications than those who stay overnight in the intervention hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Fast Track Group
The patients are discharged the same day after coronary angiography to the refering Hospital
Early discharge
The patients are discharged the same day as coronary angiography.
Group 2: Ordinary care
Ordinary Cardiology care in the Intervention hospital
Care as usual. No intervention. (Control group)
The patients are admitted and cared as usual in cardiology ward.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early discharge
The patients are discharged the same day as coronary angiography.
Care as usual. No intervention. (Control group)
The patients are admitted and cared as usual in cardiology ward.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Known mental retardation, dementia or harmful use of alcohol or drugs.
* Allergy or intolerance to ASA and / or clopidogrel.
* Patients who have previously been involved in this study.
* Acute STEMI infarction for less than 72 hours ago.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ullevaal University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ullevaal University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital, Ullevaal
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Jack Gunnar Andersen, Master of Management
Role: CONTACT
Phone: +47 98 64 16 34
Email: [email protected]
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Odd Johansen, ph. d MD
Role: primary
Jack Gunnar Andersen, Master of Management
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK: 6.2008.1724
Identifier Type: -
Identifier Source: org_study_id